SCHEMBL7393797

SCHEMBL7393797

[c]1cccc(-c2ncccn2)c1CN1CCC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ CHRNB2 P17787 1/20 0.34
▸ CHRNA4 P43681 1/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ ALOX12 P18054 1/20 0.34
▸ NFKB1 P19838 1/20 0.34
▸ NFKB2 Q00653 1/20 0.34
▸ RELA Q04206 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ HRH3 Q9Y5N1 3/20 0.33
▸ CHKA P35790 1/20 0.33
▸ PDCD1 Q15116 1/20 0.32
▸ CD274 Q9NZQ7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6643796 0.97 CYP2C19 (0.41) CYP2C19HIF1ACHRNB2CHRNA4BRD4
SCHEMBL7381788 0.95 CYP2C19 (0.43) CYP2C19HIF1ACHRNB2CHRNA4BRD4
SCHEMBL7392732 0.87 SIGMAR1 (0.41) KDM4EALDH1A1LMNAL3MBTL1
SCHEMBL7390599 0.84 HTR7 (0.40) CYP2C19HIF1AKDM4EALDH1A1LMNA
SCHEMBL6641136 0.81 TGFBR1 (0.40) CYP2C19HIF1ACHRNB2CHRNA4KDM4E
SCHEMBL7388323 0.80 CYP2C19 (0.40) CYP2C19HIF1ABRD4KDM4EALDH1A1
SCHEMBL7390870 0.78 HTR7 (0.42) CYP2C19KDM4EALDH1A1LMNATP53
SCHEMBL7385735 0.77 CHRNB2 (0.47) CHRNB2CHRNA4ALDH1A1HRH3CYP1A2
SCHEMBL6641151 0.75 OPRK1 (0.44) CYP2C19KDM4EALDH1A1LMNATP53
SCHEMBL6637618 0.74 CHRNB2 (0.50) CYP2C19HIF1ACHRNB2CHRNA4HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6060491-A ANTICOAGULANTS; THROMBOEMBOLIC DISORDERS; PROPHYLAXIS DUPONT PHARMACEUTICALS (US) 2000-05-09 — — US disclosed
EP-0993448-A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-19 — — EP disclosed
EP-0991625-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 2000-04-12 — — EP disclosed
US-5998424-A ANTICOAGULANTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-12-07 — — US disclosed
WO-1998057934-A1 (AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 — — WO disclosed
WO-1998057937-A2 INHIBITORS OF FACTOR XA WITH A NEUTRAL P1 SPECIFICITY GROUP THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-12-23 — — WO disclosed
Send feedback